Literature DB >> 15898829

Herbal interactions involving cytochrome p450 enzymes: a mini review.

Rupika Delgoda1, Andrew C G Westlake.   

Abstract

The metabolism of a drug can be altered by another drug or foreign chemical, and such interactions can often be clinically significant. Cytochrome P450 (CYP) enzymes, a superfamily of enzymes found mainly in the liver, are involved in the metabolism of a plethora of xenobiotics and have been shown to be involved in numerous interactions between drugs and food, herbs and other drugs. The observed induction and inhibition of CYP enzymes by natural products in the presence of a prescribed drug has (among other reasons) led to the general acceptance that natural therapies can have adverse effects, contrary to the popular beliefs in countries where there is an active practice of ethnomedicine. Herbal medicines such as St. John's wort, garlic, piperine, ginseng, and gingko, which are freely available over the counter, have given rise to serious clinical interactions when co-administered with prescription medicines. Such adversities have spurred various pre-clinical and in vitro investigations on a series of other herbal remedies, with their clinical relevance remaining to be established. Although the presence of numerous active ingredients in herbal medicines, foods and dietary supplements complicate experimentation, the observable interactions with CYP enzymes warrant systematic studies, so that metabolism-based interactions can be predicted and avoided more readily. This article highlights the involvement of CYP enzymes in metabolism-related drug-herb interactions and the importance of gaining a mechanism-based understanding to avoid potential adverse drug reactions, in addition to outlining other contributory factors, such as pharmacogenetics and recreational habits that may compound this important health issue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15898829     DOI: 10.2165/00139709-200423040-00004

Source DB:  PubMed          Journal:  Toxicol Rev        ISSN: 1176-2551


  27 in total

1.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation.

Authors:  J P Hernandez; L C Mota; W S Baldwin
Journal:  Curr Pharmacogenomics Person Med       Date:  2009-06-01

Review 2.  Drug transporters in pharmacokinetics.

Authors:  Ernst Petzinger; Joachim Geyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-03-11       Impact factor: 3.000

3.  Toxicogenetics--cytochrome P450 microarray analysis in forensic cases focusing on morphine/codeine and diazepam.

Authors:  H Andresen; C Augustin; T Streichert
Journal:  Int J Legal Med       Date:  2012-08-17       Impact factor: 2.686

4.  The HR96 activator, atrazine, reduces sensitivity of D. magna to triclosan and DHA.

Authors:  Namrata Sengupta; Elizabeth J Litoff; William S Baldwin
Journal:  Chemosphere       Date:  2015-03-03       Impact factor: 7.086

5.  Glaucarubulone glucoside from Castela macrophylla suppresses MCF-7 breast cancer cell growth and attenuates benzo[a]pyrene-mediated CYP1A gene induction.

Authors:  Simone A M Badal; Malyn M Asuncion Valenzuela; Dain Zylstra; George Huang; Pallavi Vendantam; Sheena Francis; Ashley Quitugua; Louisa H Amis; Willie Davis; Tzuen-Rong J Tzeng; Helen Jacobs; David J Gangemi; Greg Raner; Leah Rowland; Jonathan Wooten; Petreena Campbell; Eileen Brantley; Rupika Delgoda
Journal:  J Appl Toxicol       Date:  2017-01-31       Impact factor: 3.446

6.  Effect of eurycomanone on cytochrome P450 isoforms CYP1A2, CYP2A6, CYP2C8, CYP2C9, CYP2C19, CYP2E1 and CYP3A4 in vitro.

Authors:  Yan Pan; Kai Hung Tiong; Badrul Amini Abd-Rashid; Zakiah Ismail; Rusli Ismail; Joon Wah Mak; Chin Eng Ong
Journal:  J Nat Med       Date:  2013-07-24       Impact factor: 2.343

Review 7.  Adverse events associated with complementary and alternative medicine use in ovarian cancer patients.

Authors:  Erin S Sweet; Leanna J Standish; Barbara A Goff; M Robyn Andersen
Journal:  Integr Cancer Ther       Date:  2013-04-26       Impact factor: 3.279

8.  Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

Authors:  M Robyn Andersen; Erin Sweet; Kimberly A Lowe; Leanna J Standish; Charles W Drescher; Barbara A Goff
Journal:  J Altern Complement Med       Date:  2013-02-27       Impact factor: 2.579

9.  Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.

Authors:  Bill J Gurley; Ashley Swain; Martha A Hubbard; D Keith Williams; Gary Barone; Faith Hartsfield; Yudong Tong; Danielle J Carrier; Shreekar Cheboyina; Sunil K Battu
Journal:  Mol Nutr Food Res       Date:  2008-07       Impact factor: 5.914

Review 10.  Causality assessment in hepatotoxicity by drugs and dietary supplements.

Authors:  Rolf Teschke; Alexander Schwarzenboeck; Karl-Heinz Hennermann
Journal:  Br J Clin Pharmacol       Date:  2008-12       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.